BD to Present at Wells Fargo 2025 Healthcare Conference: Enhancing Global Health Outcomes.

BD (Becton, Dickinson and Company) will present at the Wells Fargo 2025 Healthcare Conference on September 3, 2025. The presentation will be live streamed on investors.bd.com and a replay will be available after the event. BD is a leading global medical technology company enhancing healthcare delivery worldwide.

BD (Becton, Dickinson and Company) will present at the upcoming Wells Fargo 2025 Healthcare Conference on Wednesday, September 3, 2025, at 8:00 a.m. Eastern Time. The presentation will be live-streamed on the BD investor relations website, investors.bd.com, and a replay will be available following the event [1].

BD, a leading global medical technology company, is known for its advancements in medical discovery, diagnostics, and the delivery of care. With over 70,000 employees, BD supports healthcare professionals worldwide by developing innovative technologies and solutions. The company's mission is to enhance the safety and efficiency of clinicians' care delivery processes, enable accurate disease detection, and advance research capabilities in diagnostics and therapeutics [2].

The presentation at the Wells Fargo 2025 Healthcare Conference will likely focus on BD's recent innovations, strategic initiatives, and future growth prospects. Investors and financial professionals are encouraged to tune in to gain insights into BD's contributions to the healthcare sector and its role in addressing global health challenges [3].

References:

[1] https://www.biospace.com/press-releases/bd-to-present-at-wells-fargo-2025-healthcare-conference
[2] https://www.nasdaq.com/press-release/bd-present-wells-fargo-2025-healthcare-conference-2025-08-14
[3] https://investors.bd.com/news-events/press-releases/detail/900/bd-to-present-at-wells-fargo-2025-healthcare-conference